
Nirogmay Global Medisol Private Limited
About Nirogmay Global Medisol Private Limited
Data last updated:
Nirogmay Global Medisol Private Limited was a private limited company based in Ghaziabad, Uttar Pradesh, India. The company has been struck off by the Registrar of Companies, typically due to non-filing of annual returns or failure to commence business. It is no longer operational and cannot enter into any legal contracts or agreements. It operated in the wholesale trading and distribution segment of the trading and commerce sector. It was incorporated on 02 May 2017.
The company was registered with the Registrar of Companies (ROC), Kanpur, under CIN U51909UP2017PTC092841.
The company had an authorised share capital of ₹5 Lakh and a paid-up capital of ₹5 Lakh. It was led by directors Satya Prakash Tripathi and Suman Tripathi.
Its last annual general meeting (AGM) was held on 29 September 2018, and its latest financial statements are for the year ended 31 March 2018. The registered office was at Sj – 46 Diamond Palace Shastri Nagar, Ghaziabad, Uttar Pradesh, India – 201002.
Company details
Contact details
Nirogmay Global Medisol Private Limited's registered office is in Ghaziabad, Uttar Pradesh.
- Registered AddressSj – 46 Diamond Palace Shastri Nagar, Ghaziabad, Uttar Pradesh, India – 201002
- IndustryTrading, Wholesale, Specialty
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Nirogmay Global Medisol Private Limited
FY 2018 filings availableFinancial Statement Summary
| Metrics | FY 2017-18 |
|---|---|
| Profit and Loss Statement | |
| Revenue from Operations | |
| Other Income | |
| Total Revenue | |
| Cost of Materials Consumed | |
| Employee Benefit Expense | |
| Finance Costs | |
| Depreciation and Amortisation | |
| Other Expenses | |
| Total Expenses | |
| EBITDA | |
| Profit Before Tax | |
| Tax Expense | |
| Net Profit (PAT) | |
| Balance Sheet | |
| Share Capital | |
| Reserves and Surplus | |
| Net Worth (Total Equity) | |
| Long-term Borrowings | |
| Short-term Borrowings | |
| Trade Payables | |
| Total Liabilities | |
| Fixed Assets | |
| Investments | |
| Inventories | |
| Trade Receivables | |
| Cash and Bank Balance | |
| Total Assets | |
Financial Ratios
| Metrics | FY 2017-18 |
|---|---|
| Profitability | |
| EBITDA Margin | |
| Net Profit Margin | |
| Return on Equity (ROE) | |
| Return on Capital Employed (ROCE) | |
| Return on Assets (ROA) | |
| Liquidity and Debt | |
| Current Ratio | |
| Quick Ratio | |
| Debt-to-Equity Ratio | |
| Interest Coverage Ratio | |
| Efficiency and Growth | |
| Asset Turnover | |
| Receivable Days | |
| Payable Days | |
| Inventory Days | |
| Revenue Growth | |
| Net Profit Growth | |
To see the full financial statements and ratios of Nirogmay Global Medisol Private Limited, buy the company report.
Board of directors of Nirogmay Global Medisol Private Limited
Nirogmay Global Medisol has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Satya Prakash Tripathi Also directs: Gowell Services India Private Limited | Director | 02 May 2017 | 9 Years 5 Months | As last reported |
| Suman Tripathi | Director | 02 May 2017 | 9 Years 5 Months | As last reported |
Legal cases
No court or tribunal cases involving Nirogmay Global Medisol Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Nirogmay Global Medisol Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Nirogmay Global Medisol Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Nirogmay Global Medisol Private Limited has 2 board changes on record since 2017: 2 appointments. The latest: Satya Prakash Tripathi was appointed as Director on 02 May 2017.
Frequently asked questions
Nirogmay Global Medisol has a status of "Struck Off" as per MCA records. This means the company has been officially removed from the Register of Companies, typically due to non-filing of annual returns or failure to commence business within one year of incorporation. A struck-off company cannot enter into any legal contracts or agreements, and any dealings with such an entity carry significant legal and financial risk.
Nirogmay Global Medisol was a private limited company based in Ghaziabad, Uttar Pradesh, India. The company worked in wholesale, within the trading industry. It was incorporated on 02 May 2017 and is registered under CIN U51909UP2017PTC092841. The company has been struck off by the Registrar of Companies and is no longer operational.
Nirogmay Global Medisol had 2 directors:
- Satya Prakash Tripathi - Director
- Suman Tripathi - Director
The CIN (Corporate Identification Number) of Nirogmay Global Medisol is U51909UP2017PTC092841. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The registered office of Nirogmay Global Medisol is at Sj – 46 Diamond Palace Shastri Nagar, Ghaziabad, Uttar Pradesh, India – 201002.
Nirogmay Global Medisol was incorporated on 02 May 2017. It is registered with the Registrar of Companies, Kanpur.
The latest financial statements of Nirogmay Global Medisol on record with the MCA are for the year ended 31 March 2018. Its last annual general meeting was held on 29 September 2018. Year-wise statements from FY 2018 are in the company report.
Nirogmay Global Medisol operated in the trading industry, in the wholesale segment. It worked in this industry before it was struck off.
Satya Prakash Tripathi was appointed as Director on 02 May 2017. Suman Tripathi was appointed as Director on 02 May 2017.
The compliance status of Nirogmay Global Medisol is compliant as of 20 September 2026.

